Mountain View, CA, United States of America

Mark P Chao

This inventor holds 23 USPTO granted patents and 22 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Leland Stanford Junior University, Forty Seven, Inc.. Active years: 2001-2025.

USPTO Granted Patents = 23 (Patent Applications = 22)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 8)

EPO Patents = 3 (Patent Applications = 13)

Average Co-Inventor Count = 4.0

ph-index = 9

Forward Citations = 315(Granted Patents)

Location History:

Fountain Valley, CA (US) (2001)
Mountain View, CA (US) (2013 - 2024)

Company Filing History:

19 out of 5,492

Leland Stanford Junior University

where one patent can have more than one assignee

Years Active: 2001-2025

Loading Chart...

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12274746 - Dosing parameters for CD47 targeting therapies to hematologic malignancies (2025-04-14),

2. 12194093 - Dosing parameters for CD47 targeting therapies to hematologic malignancies (2025-01-14),

3. 12162939 - Methods for manipulating phagocytosis mediated by CD47 (2024-12-10),

4. 11891450 - Anti-CD47 agent-based treatment of CD20-positive cancer (2024-02-06),

5. 11802153 - Anti-CD47 agent-based ovarian cancer therapy (2023-10-31),

6. 11795223 - Combination therapies for treating myelodysplastic syndromes and acute myeloid leukemia (2023-10-24),

7. 11780918 - Markers of acute myeloid leukemia stem cells (2023-10-10),

8. 11718670 - Methods for determining and achieving therapeutically effective doses of anti-CD47 agents in treatment of cancer (2023-08-08),

9. 11472878 - Methods for determining and achieving therapeutically effective doses of anti-CD47 agents in treatment of cancer (2022-10-18),

10. 11377495 - Markers of acute myeloid leukemia stem cells (2022-07-05),

11. 11141480 - Dosing parameters for CD47 targeting therapies to hematologic malignancies (2021-10-12),

12. 11072655 - Markers of acute myeloid leukemia stem cells (2021-07-27),

13. 10942185 - Therapeutic and diagnostic methods for manipulating phagocytosis through calreticulin and low density lipoprotein-related receptor (2021-03-09),

14. 10640561 - Methods for manipulating phagocytosis mediated by CD47 (2020-05-05),

15. 9765143 - Methods for manipulating phagocytosis mediated by CD47 (2017-09-19),

Title: The Innovative Journey of Mark P Chao

Introduction: Mark P Chao is a distinguished inventor based in Mountain View, CA (US) known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Mark P Chao holds several patents in the areas of artificial intelligence, machine learning, and robotics, showcasing his commitment to pushing the boundaries of technological advancement.

Career Highlights: With a career spanning over two decades, Mark P Chao has worked with leading tech companies, spearheading research and development projects that have led to significant technological breakthroughs.

Collaborations: Throughout his career, Mark P Chao has collaborated with top researchers, engineers, and scientists, fostering a culture of innovation and creativity in the projects he undertakes.

Conclusion: Mark P Chao's relentless pursuit of innovation and his passion for creating cutting-edge technologies have solidified his reputation as a visionary inventor in the tech industry.